Short-term outcomes of acute low-tone sensorineural hearing loss according to treatment modality

Jinkyung Chang, Gunhwee Yum, Ha Young Im, Jong Yoon Jung, Yoon Chan Rah, June Choi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background and Objectives: We compared improvements in hearing thresholds in acute low-tone sensorineural hearing loss (ALHL) patients after two different treatments: steroid alone and steroid and diuretic combined. We analyzed how the duration between the onset of symptoms and the initiation of treatment affected hearing loss improvement and investigated the relation between presence of vertigo in ALHL patients and ALHL progression to Ménière's disease (MD). Subjects and Methods: We retrospectively analyzed the medical records of 47 ALHL patients aged 21 to 76 years. Patients received either orally administered steroid alone (n=12) or steroid and diuretic combined (n=35). We compared improvements in the two groups' hearing thresholds at three lower frequencies (125, 250, and 500 Hz) after participants had received one month of each respective treatment. Results: Our two treatments did not show any statistical difference in hearing loss improvement after one month. Forty percent of ALHL patients with vertigo developed MD, which was a significantly higher rate than the 12.5% of ALHL patients without vertigo who developed MD. The shorter duration between the onset of symptoms and the initiation of treatment significantly increased improvement in the sum of lower frequency hearing threshold after one month. Conclusions: The current study suggests that steroid and diuretic administered together and steroid alone similarly improve the hearing threshold in ALHL patients after one month. We concluded that patients should initiate ALHL treatment as soon as they experience symptoms. ALHL patients should also be notified of their higher risk of developing MD.

Original languageEnglish
Pages (from-to)47-52
Number of pages6
JournalJournal of audiology and otology
Volume20
Issue number1
DOIs
Publication statusPublished - 2016 Jan 1

Fingerprint

Sensorineural Hearing Loss
Steroids
Hearing
Vertigo
Diuretics
Therapeutics
Hearing Loss
Medical Records

Keywords

  • Acute low-tone sensorineural hearing loss
  • Combination
  • Diuretic
  • Steroid

ASJC Scopus subject areas

  • Sensory Systems
  • Speech and Hearing

Cite this

Short-term outcomes of acute low-tone sensorineural hearing loss according to treatment modality. / Chang, Jinkyung; Yum, Gunhwee; Im, Ha Young; Jung, Jong Yoon; Rah, Yoon Chan; Choi, June.

In: Journal of audiology and otology, Vol. 20, No. 1, 01.01.2016, p. 47-52.

Research output: Contribution to journalArticle

Chang, Jinkyung ; Yum, Gunhwee ; Im, Ha Young ; Jung, Jong Yoon ; Rah, Yoon Chan ; Choi, June. / Short-term outcomes of acute low-tone sensorineural hearing loss according to treatment modality. In: Journal of audiology and otology. 2016 ; Vol. 20, No. 1. pp. 47-52.
@article{031841a2b6944267b084cdf5a3a04e63,
title = "Short-term outcomes of acute low-tone sensorineural hearing loss according to treatment modality",
abstract = "Background and Objectives: We compared improvements in hearing thresholds in acute low-tone sensorineural hearing loss (ALHL) patients after two different treatments: steroid alone and steroid and diuretic combined. We analyzed how the duration between the onset of symptoms and the initiation of treatment affected hearing loss improvement and investigated the relation between presence of vertigo in ALHL patients and ALHL progression to M{\'e}ni{\`e}re's disease (MD). Subjects and Methods: We retrospectively analyzed the medical records of 47 ALHL patients aged 21 to 76 years. Patients received either orally administered steroid alone (n=12) or steroid and diuretic combined (n=35). We compared improvements in the two groups' hearing thresholds at three lower frequencies (125, 250, and 500 Hz) after participants had received one month of each respective treatment. Results: Our two treatments did not show any statistical difference in hearing loss improvement after one month. Forty percent of ALHL patients with vertigo developed MD, which was a significantly higher rate than the 12.5{\%} of ALHL patients without vertigo who developed MD. The shorter duration between the onset of symptoms and the initiation of treatment significantly increased improvement in the sum of lower frequency hearing threshold after one month. Conclusions: The current study suggests that steroid and diuretic administered together and steroid alone similarly improve the hearing threshold in ALHL patients after one month. We concluded that patients should initiate ALHL treatment as soon as they experience symptoms. ALHL patients should also be notified of their higher risk of developing MD.",
keywords = "Acute low-tone sensorineural hearing loss, Combination, Diuretic, Steroid",
author = "Jinkyung Chang and Gunhwee Yum and Im, {Ha Young} and Jung, {Jong Yoon} and Rah, {Yoon Chan} and June Choi",
year = "2016",
month = "1",
day = "1",
doi = "10.7874/jao.2016.20.1.47",
language = "English",
volume = "20",
pages = "47--52",
journal = "Journal of audiology and otology",
issn = "2384-1621",
publisher = "Korean Audiological Society",
number = "1",

}

TY - JOUR

T1 - Short-term outcomes of acute low-tone sensorineural hearing loss according to treatment modality

AU - Chang, Jinkyung

AU - Yum, Gunhwee

AU - Im, Ha Young

AU - Jung, Jong Yoon

AU - Rah, Yoon Chan

AU - Choi, June

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Background and Objectives: We compared improvements in hearing thresholds in acute low-tone sensorineural hearing loss (ALHL) patients after two different treatments: steroid alone and steroid and diuretic combined. We analyzed how the duration between the onset of symptoms and the initiation of treatment affected hearing loss improvement and investigated the relation between presence of vertigo in ALHL patients and ALHL progression to Ménière's disease (MD). Subjects and Methods: We retrospectively analyzed the medical records of 47 ALHL patients aged 21 to 76 years. Patients received either orally administered steroid alone (n=12) or steroid and diuretic combined (n=35). We compared improvements in the two groups' hearing thresholds at three lower frequencies (125, 250, and 500 Hz) after participants had received one month of each respective treatment. Results: Our two treatments did not show any statistical difference in hearing loss improvement after one month. Forty percent of ALHL patients with vertigo developed MD, which was a significantly higher rate than the 12.5% of ALHL patients without vertigo who developed MD. The shorter duration between the onset of symptoms and the initiation of treatment significantly increased improvement in the sum of lower frequency hearing threshold after one month. Conclusions: The current study suggests that steroid and diuretic administered together and steroid alone similarly improve the hearing threshold in ALHL patients after one month. We concluded that patients should initiate ALHL treatment as soon as they experience symptoms. ALHL patients should also be notified of their higher risk of developing MD.

AB - Background and Objectives: We compared improvements in hearing thresholds in acute low-tone sensorineural hearing loss (ALHL) patients after two different treatments: steroid alone and steroid and diuretic combined. We analyzed how the duration between the onset of symptoms and the initiation of treatment affected hearing loss improvement and investigated the relation between presence of vertigo in ALHL patients and ALHL progression to Ménière's disease (MD). Subjects and Methods: We retrospectively analyzed the medical records of 47 ALHL patients aged 21 to 76 years. Patients received either orally administered steroid alone (n=12) or steroid and diuretic combined (n=35). We compared improvements in the two groups' hearing thresholds at three lower frequencies (125, 250, and 500 Hz) after participants had received one month of each respective treatment. Results: Our two treatments did not show any statistical difference in hearing loss improvement after one month. Forty percent of ALHL patients with vertigo developed MD, which was a significantly higher rate than the 12.5% of ALHL patients without vertigo who developed MD. The shorter duration between the onset of symptoms and the initiation of treatment significantly increased improvement in the sum of lower frequency hearing threshold after one month. Conclusions: The current study suggests that steroid and diuretic administered together and steroid alone similarly improve the hearing threshold in ALHL patients after one month. We concluded that patients should initiate ALHL treatment as soon as they experience symptoms. ALHL patients should also be notified of their higher risk of developing MD.

KW - Acute low-tone sensorineural hearing loss

KW - Combination

KW - Diuretic

KW - Steroid

UR - http://www.scopus.com/inward/record.url?scp=84965081805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84965081805&partnerID=8YFLogxK

U2 - 10.7874/jao.2016.20.1.47

DO - 10.7874/jao.2016.20.1.47

M3 - Article

AN - SCOPUS:84965081805

VL - 20

SP - 47

EP - 52

JO - Journal of audiology and otology

JF - Journal of audiology and otology

SN - 2384-1621

IS - 1

ER -